Panic Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Does prior traumatization affect the treatment outcome of CBT for panic disorder? The potential role of the MAOA gene and depression symptoms.
|
28712090 |
2019 |
Panic Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
The present results support previous evidence for MAOA hypomethylation as a PD risk marker and suggest reversibility of MAOA hypomethylation as a potential epigenetic correlate of response to CBT.
|
27045843 |
2016 |
Panic Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy.
|
23319006 |
2014 |
Panic Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
The present pilot data suggest a potential role of MAOA gene hypomethylation in the pathogenesis of panic disorder particularly in female patients, possibly mediating a detrimental influence of negative life events.
|
22436428 |
2012 |
Panic Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Taken together, our meta-analysis therefore argues that high-expression MAOA-uVNTR alleles significantly increase the risk towards PD in women.
|
22911667 |
2012 |
Panic Disorder
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
With regard to the MAOA gene, a sequence variant that increases MAOA activity and has suggested association with the anxiety condition, panic disorder was preferentially transmitted from parents to affected children.
|
15523490 |
2005 |
Panic Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
This study was conducted to detect a possible association of a T941G single nucleotide polymorphism (SNP) in the monoamine oxidase A (MAOA) gene with generalized anxiety disorder (GAD), panic disorder (PD), or major depression (MD).
|
12555227 |
2003 |
Panic Disorder
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression.
|
12555227 |
2003 |
Panic Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
An analysis of possible synergistic effects of the MAO-A gene promoter variant and the short serotonin transporter (5-HTT) gene promoter variant in panic disorder was performed in a German and an Italian sample (combined panic disorder n = 144, combined controls n = 175).
|
12607224 |
2000 |
Panic Disorder
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
An analysis of possible synergistic effects of the MAO-A gene promoter variant and the short serotonin transporter (5-HTT) gene promoter variant in panic disorder was performed in a German and an Italian sample (combined panic disorder n = 144, combined controls n = 175).
|
12607224 |
2000 |
Panic Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Recently, a positive association between panic disorder and a novel functional repeat polymorphism in the MAO-A gene promoter, with the longer alleles being more active, was reported.
|
11121185 |
2000 |
Panic Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Together with the observation that inhibition of monoamine oxidase A is clinically effective in the treatment of panic disorder these findings suggest that increased monoamine oxidase A activity is a risk factor for panic disorder in female patients.
|
10072430 |
1999 |